Cargando…

Association of SARS-CoV-2 infection and persistence with long COVID

Detalles Bibliográficos
Autores principales:	Yang, Chengliang, Zhao, Hedi, Espín, Estefanía, Tebbutt, Scott J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171832/ https://www.ncbi.nlm.nih.gov/pubmed/37178694 http://dx.doi.org/10.1016/S2213-2600(23)00142-X

Ejemplares similares

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Long COVID: the next public health crisis is already on its way
por: Yang, Chengliang, et al.
Publicado: (2023)

Persistent symptoms after SARS-CoV-2 infection: Long-term implications for health and quality of life
por: So, Mike K.P., et al.
Publicado: (2022)

Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials
por: Moran, Ed, et al.
Publicado: (2021)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
por: Brightling, Christopher E, et al.
Publicado: (2022)

COVID-19 vaccination in patients with α1-antitrypsin deficiency
por: Yang, Chengliang, et al.
Publicado: (2021)

A glimpse into long COVID and symptoms
por: Yang, Chengliang, et al.
Publicado: (2022)

Long-term effects on survivors with COVID-19
por: Yang, Chengliang, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Diabetes after SARS-CoV-2 infection
por: Al-Aly, Ziyad
Publicado: (2023)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

Cellular and molecular biomarkers of long COVID: a scoping review
por: Espín, Estefanía, et al.
Publicado: (2023)

SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship
por: Skevaki, Chrysanthi, et al.
Publicado: (2021)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Correlates of protection from SARS-CoV-2 infection
por: Krammer, Florian
Publicado: (2021)

Escalating burden of SARS-CoV-2 infection in Ethiopia
por: Adane, Kelemework, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19
por: Heimbach, Julie K, et al.
Publicado: (2020)

Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
por: van Westen-Lagerweij, Naomi A., et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

SARS-CoV-2 immunity and HIV infection: total recall?
por: Dauby, Nicolas, et al.
Publicado: (2021)

The mechanisms of smell loss after SARS-CoV-2 infection
por: Doty, Richard L
Publicado: (2021)

How to interpret the total number of SARS-CoV-2 infections
por: Shioda, Kayoko, et al.
Publicado: (2022)

Neuroinflammation triggered by SARS-CoV-2 infection: syndromes and therapies
por: Dale, Russell C, et al.
Publicado: (2021)

Early treatment to prevent progression of SARS-CoV-2 infection
por: Cohen, Myron S
Publicado: (2022)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
por: Talarico, Rosaria, et al.
Publicado: (2020)

Protective immunity after recovery from SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
por: Sigal, Alex, et al.
Publicado: (2022)

Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
por: Garg, Pramod Kumar, et al.
Publicado: (2022)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children
por: Yang, Chengliang, et al.
Publicado: (2021)

Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t9tb70t0rvkfu20v246lrdo9uc